Noxafil and graft versus host disease Patient Reports February 12, 2012

Noxafil Side Effects Report #5165183-7
Noxafil side effect was reported by a Physician from FRANCE on Nov 17, 2006. Male patient, 27 years of age, weighting 132.3 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Noxafil. After drug was administered, patient experienced the following side effects: blood bilirubin increased, cholestasis, graft versus host disease, hepatotoxicity. Noxafil dosage: 400 MG BID PO. During the same period patient was treated with TIENAM, OFLOCET, ZOVIRAX, VANOMYCINE, SOMUMEDROL, AMBISOME, SPASFON, ACTRAPID. Patient died.

Noxafil Side Effects Report #6088514-2
Noxafil side effect was reported by a Physician from FINLAND on Feb 10, 2009. Male patient, 51 years of age, was diagnosed with antifungal prophylaxis and was treated with Noxafil. After drug was administered, patient experienced the following side effects: catheter related infection, graft versus host disease, systemic candida, transmission of an infectious agent via a medicinal product. Noxafil dosage: 200 MG; TID;. During the same period patient was treated with CASPOFUNGIN, AMBISOME, FLUCONAZOLE. Patient died on 02/01/2008.

Noxafil Side Effects Report #6001899-8
Noxafil side effect was reported by a Physician from UNITED STATES on Dec 09, 2008. Female patient, 51 years of age, was diagnosed with acute myeloid leukaemia and was treated with Noxafil. After drug was administered, patient experienced the following side effects: graft versus host disease. Noxafil dosage: unknown. Patient died on 11/18/2008.

Noxafil Side Effects Report #5150866-5
Noxafil side effect was reported by a Physician from FRANCE on Nov 02, 2006. Male patient, 27 years of age, was treated with Noxafil. After drug was administered, patient experienced the following side effects: cholestasis, condition aggravated, graft versus host disease. Noxafil dosage: unknown. Patient recovered.